Lee H W, Kim E N, Son H J, Ahn S K, Chung K H, Kim J W, Lee C R
Research Institute, Chong Kun Dang Corp., Seoul, Korea.
Chem Pharm Bull (Tokyo). 1996 Dec;44(12):2326-30. doi: 10.1248/cpb.44.2326.
A series of new carbapenem derivatives, which have a pyrrolidin-4-ylthio group substituted with a hydroxyalkyl or carbamoyl group at the 2' position as the C-2 side chain, have been prepared. The antibacterial activity and the stability to renal dehydropeptidase-I of these compounds were investigated, and the structure-activity relationships were studied. Among these new carbapenems, (1R,5S,6S)-2-[(2S,4S)-2-¿(2-hydroxy)ethylmercaptomethyl¿pyrroli din-4 -ylthio]-6-[(1R)-I-hydroxyethyl]-1-methyl-1-carbapen-2-em-3- carboxylic acid (1a) showed the most potent and well balanced activity and was selected as a candidate for further evaluation.